Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


The increasing number of the patients with diabetes who use insulin for treatment makes the study of side effects to the above mentioned medicines important and relevant. Due to the current use of human genetically engineered insulin analogues, complications caused by their use develop less often. We described the case of an allergic reaction to the аctrapid and рrotaphane in a patient with Type 1 Diabetes manifested in the form of chronic, recurrent urticaria and angioedema. Sensitization to the above mentioned insulin preparations was proved clinically and with specific immunoallergological methods. The replacement of insulin preparations caused a stable clinical effect.

Full Text

Restricted Access

About the authors

A S Prylutski

Donetsk National Medical University named after Gorky

212, Port-Arturnaya str., Donetsk, 83060, DPR

O A Prylutskaya

Donetsk National Medical University named after Gorky

212, Port-Arturnaya str., Donetsk, 83060, DPR

E S Polkovnik

Donetsk National Medical University named after Gorky

212, Port-Arturnaya str., Donetsk, 83060, DPR


  1. Heinzerling L, Raile K, Rochlitz H, Zuberbier T, Worm M. Insulin allergy: clinical manifestations and management strategies. Allergy. 2008; 63: 148-155. doi: 10.1111/j.1398-9995.2007.01567.x.
  2. DeShazo RD, Mather P, Grant W, Isidro ML. Evaluation of patients with local reactions to insulin with skin test and in vitro techniques. Diabetes Care. 1987; 10: 330-336. doi: 10.2337/diacare.10.3.330.
  3. Lieberman P, Patterson R, Metz R, Ucena G. Allergic reactions to insulin. JAMA. 1971; 215: 1106-1112. doi: 10.1001/jama.1971.03180200030006.
  4. Marcos C, Cuesta J, Cuevas M, Balsa J, Fraj J, Alvarez-Cuesta E. Specific IgE antibody response to human insulin in diabetic subjects. Allergol Immunopathol (Madr.). 1993; 21: 141-144.
  5. Ai-Young L, Won-Young C, Joon C, Jae-Seok J. Clinical report. Insulin-induced Drug Eruptions and Reliability of Skin Tests. Acta Derm Venereol. 2002; 82: 114-117.
  6. Прилуцкий АС, Лесниченко ДА, Кузнецова ЛВ, Прилуцкая ИА, Пузик АА, Назаренко АП. и соавт. Оценка аналитической чувствительности, вариабельности и сравнительный анализ ИФА тест-систем для определения специфического IgE. Імунологія та алергологія: наука і практика. 2014; 1: 70-74.
  7. Прилуцкий АС, Мацегора АС, Кузнецова ЛВ, Назаренко АП, Борзенко БГ, Евтушенко СК. Сравнительный анализ ИФА тест-систем для определения специфических IgE методом ROC-кривых. Лабораторна діагностика. 2014; (69): 10-14
  8. Bavbek S, Lee MJ. Subcutaneous Injectable Drugs Hypersensitivity and Desensitization: Insulin and Monoclonal Antibodies. Immunol Allergy Clin North Am. 2017; 37: 761-771. doi: 10.1016/j.iac.2017.06.001.
  9. Ghazavi MK, Johnston GA. Insulin allergy. Clinics in Dermatology. 2011; 29: 300-305. doi: 10.1016/j.clindermatol.2010.11.009.
  10. Jacquier J, Chik CL, Senior PA. A practical, clinical approach to the assessment and management of suspected insulin allergy. Diabetic Medicine. 2013; 30: 977-985. doi: 10.1111/dme.12194.
  11. Morton A, Laurie J. Allergic reactions to insulin detemir in women with gestational diabetes mellitus. Australian Family Physician. 2017; 45: 485-486.
  12. Kaya A, Gungor K, Karakose S. Severe anaphylactic reaction to human insulin in a diabetic patient. J Diabetes Complications. 2007; 21: 124-127. doi: 10.1016/j.jdiacomp.2006.05.003.
  13. Radermecker RP, Scheen AJ. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev. 2007; 23: 348-355. doi: 10.1002/dmrr.714.
  14. Wessbecher R, Kiehn M, Stoffell E, Moll I. Management of insulin allergy. Allergy. 2001; 56: 919-920. doi: 10.1034/j.1398-9995.2001.00225.x.
  15. Wu P, Ji C, Wang M, Zou S, Ge W. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine. Ann Endocrinol. 2013; 74: 56-58. doi: 10.1016/j.ando.2012.11.005.
  16. Akinci B, Yener S, Bayraktar F, Yesil S. Allergic reactions to human insulin: a review of current knowledge and treatment options. Endocrine. 2010; 37: 33-39. doi: 10.1007/s12020-009-9256-1.
  17. Kumar D. Lispro analog for treatment of generalised allergy to human insulin. Diabеtes Care. 1997; 20: 1357-1359.
  18. Blanco C, Castillo R, Quiralte J, Delgado J, Garcia I, De Pablos P. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy: European Journal of Allergy and Clinical Immunology. 1996; 51: 421-424. doi: 10.1111/j.1398-9995.1996.tb00153.x.
  19. Yokoyama H, Fukumoto S, Koyama H, Emoto M, Kitagawa Y, Nishizawa Y. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering. Diabetes Research and Clinical Practice. 2003; 61: 161-166. doi: 10.1016/S0168-8227(03)00114-1.
  20. Takatsuki H, Ishii H, Yamauchi T, Nakashima N, Nagase S, Hisatomi A et al. A case of insulin allergy: the crystalline human insulin may mask its antigenicity. Diabetes Research and Clinical Practice. 1991; 12: 137-139. doi: 10.1016/0168-8227(91)90091-Q.
  21. Ratner RE, Phillips TM. Persistent cutaneous insulin allergy resulting from high- molecular-weight insulin aggregates. Diabetes Care. 1990; 39: 728-733. doi: 10.2337/diabetes.39.6.728.
  22. Ottesen JL, Nilsson P, Jami J, Weilguny D, Duhrkop M, Buc-chini D. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia. 1994; 37: 1178-1185. doi: 10.1007/BF00399790.
  23. Mollar-Puchades MA, Villanueva IL. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs. Diabetes Res Clin Pract. 2009; 83(1): 21-22. doi: 10.1016/j.diabres.2008.11.002.
  24. Eguíluz-Gracia I, Rodriguez-Alvarez M, Cimarra-Alvarez M, Sanabria-Pérez MC, Martinez-Côcera C. Desensitization for insulin allergy: a useful treatment also for local forms. J Investig Allergol Clin Immunol. 2012; 22: 215-216.
  25. Badik J, Chen J, Letvak K, So TY Hypersensitivity Reaction to Insulin Glargine and Insulin Detemir in a Pediatric Patient: A Case Report. J Pediatr Pharmacol Ther. 2016; 21: 85-91. doi: 10.5863/1551-6776-21.1.85.
  26. Teixeira Rodrigues A, Ensina LF, Sabino Garro L, Kase Tanno L, Giavina-Bianchi P, Motta AA. Human insulin allergy: four case reports. 2013; 30: 977-985. doi: 10.1111/dme.12194.
  27. Sambamurthy K. Pharmaceutical Biotechnology. New Delhi. New Age International. 2006; 504.
  28. Mohan V. Which insulin to use? Human or animal? CURRENT SCIENCE. 2002; 12: 1544-1547.
  29. Pföhler C, Müller CS, Hasselmann DO, Tilgen W Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report. J Med Case Reports. 2008; 2: 283. doi: 10.1186/1752-1947-2-283.
  30. Aujero MP, Brooks S, Li N, Venna S. Severe serum sickness-like type III reaction to insulin detemir. Journal of the American Academy of Dermatology. 2011; 64: 127-128. doi: 10.1016/j.jaad.2010.11.028.
  31. Kim R. Anaphylaxis to protamine masquerading as an insulin allergy. Del Med J. 1993; 65: 17-23.
  32. Bollinger ME, Hamilton RG, Wood RA. Protamine allergy as a complication of insulin hypersensitivity: A case report. J Allergy Clin Immunol. 1999; 104: 462-465. doi: 10.1016/S0091-6749(99)70394-5.
  33. Mastrorilli C, Rizzuti L, Cangelosi AM, Iovane B, Chiari G, Caffarelli C. Long-acting insulin allergy in a diabetic child. Int J Immunopathol Pharmacol. 2017; 30: 174-177. doi: 10.1177/0394632017700431



Abstract: 158

PDF (Russian): 1

Article Metrics

Metrics Loading ...



Copyright © Pharmarus Print Media, 2017

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies